ASHLEY WEISS: Open Payments
NPI 1164682571 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,319 in 18 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $265 · 2025 $7,319
Consulting: $6,000Travel & lodging: $770Food & beverage: $511Education: $39
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $7,211 |
| Lundbeck LLC | 1 | $39 |
| Alkermes, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, REXULTI, ARISTADA, INGREZZA, UZEDY.
Industry payments across LA — which companies pay providers there.
